Tarsus Pharmaceuticals
TARS
TARS
73 hedge funds and large institutions have $292M invested in Tarsus Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
43% more funds holding
Funds holding: 51 → 73 (+22)
31% more capital invested
Capital invested by funds: $222M → $292M (+$69.5M)
12.1% more ownership
Funds ownership: 63.79% → 75.89% (+12%)
Holders
73
Holding in Top 10
2
Calls
$1.1M
Puts
$11K
Top Buyers
| 1 | +$26.8M | |
| 2 | +$19.9M | |
| 3 | +$12.3M | |
| 4 |
BlackRock
New York
|
+$8.64M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.49M |
Top Sellers
| 1 | -$10.1M | |
| 2 | -$547K | |
| 3 | -$63.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$56.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$52.9K |